Abstract
Relevance: PET/CT has become an integral part of the diagnostic algorithm in lymphoma patients since lymphomas actively accumulate 18F-FDG. The high accuracy of PET/CT in patients with certain lymphoma types allows effective use of this method in clinical practice
 for diagnosis, staging, re-staging, evaluating the effectiveness of treatment, and determining further patient management tactics.
 The study aimed to evaluate the PET/CT capacity in assessing lymphoma treatment effectiveness.
 Methods: We conducted a retrospective analysis of PET/CT 18F-FDG results in 109 patients with a verified lymphoma diagnosis. The
 patients underwent PET/CT examinations at “Orhun Medical” PET/CT center based in the JSC “Kazakh Institute of Oncology and Radiology” (Almaty, Kazakhstan).
 Results: According to PET/CT results in assessing the lymphoma treatment effectiveness, the stabilization of the process was achieved
 in 38.5% of cases, progression – in 33.03%, a partial metabolic response – in 18.35%, and a complete response – in 10.09% of cases.
 Conclusion: PET/CT is the method of choice for evaluating the effectiveness of lymphoma treatment compared to other radiological
 techniques. PET/CT is based on determining metabolic treatment response, not only on size indicators. It plays an essential role in different
 stages of lymphoma treatment, providing new opportunities for personalized treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.